Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 3, 1999Science

Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs

View Full Paper
Ask AI
Bookmark
Share

Authors

HJHassan JomaaCentre National de la Recherche ScientifiqueJWJochen WiesnerFraunhofer Institute for Molecular Biology and Applied EcologySSSilke SanderbrandUniversitätsklinikum Gießen und Marburg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jomaa et al. (1999) studied this question.

synapsesocial.com/papers/6a01da48449274ec075cb706https://doi.org/10.1126/science.285.5433.1573
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells1999 · 70 citations
  2. 2Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate1993 · 1,217 citations
  3. 3Biochemistry of Polyisoprenoid Biosynthesis1976 · 182 citations
  4. 4A New Year Greeting From a New Editor1998 · 57 citations
  5. 5A family of transketolases that directs isoprenoid biosynthesis via a mevalonate-independent pathway1998 · 360 citations